FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091352 [Registered on: 22/07/2025] Trial Registered Prospectively
Last Modified On: 14/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Study to Compare the Benefits of Herbal Water Therapy and Plain Water Therapy in People with Early- Stage High Blood Pressure 
Scientific Title of Study   A Comparative Study on Efficacy of Kashayadhara and Jaladhara in Pre-Hypertension. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Reshmi Babu 
Designation  Phd Scholar 
Affiliation  Faculty of Indian Medical System, SGT University  
Address  Department of Panchakarma Faculty of Indian Medical System SGT University Gurugram

Gurgaon
HARYANA
122505
India 
Phone  9620704180  
Fax    
Email  drreshmibabu@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rekha Phull 
Designation  HOD and Professor Kayachikitsa 
Affiliation  Faculty of Indian Medical System, SGT University  
Address  Department of Kayachikitsa Faculty of Indian Medical System SGT University Gurugram

Gurgaon
HARYANA
122505
India 
Phone  9555953332  
Fax    
Email  rekha.ayurveda@sgtuniversity.org  
 
Details of Contact Person
Public Query
 
Name  Dr Reshmi Babu 
Designation  Phd Scholar 
Affiliation  Faculty of Indian Medical System, SGT University  
Address  Department of Panchakarma Faculty of Indian Medical System SGT University Gurugram

Gurgaon
HARYANA
122505
India 
Phone  9620704180  
Fax    
Email  drreshmibabu@gmail.com  
 
Source of Monetary or Material Support  
Nil,its a Phd study in private college 
 
Primary Sponsor  
Name  Dr Reshmi Babu 
Address  Department of Panchakarma Faculty of Indian Medical System SGT University  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Reshmi Babu  G S Ayurveda Medical College and Hospital  G S Ayurveda Medical College and Hospital,Department of Panchakarma, Panchakarma hospital wing,first Floor,Shirodhara Kaksha,Pilakhuwa,Hapur
Ghaziabad
UTTAR PRADESH 
9620704180

drreshmibabu@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC of G S Ayurveda Medical College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:R030||Elevated blood-pressure reading, without diagnosis of hypertension. Ayurveda Condition: VATAVYADHIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-shirodhara (Procedure Reference: Shirodhara – Sahasrayoga Taila Yoga Prakarana & standard Panchakarma protocols, Procedure details: Shirodhara with Jatamayadi Kashaya, 52 minutes daily for 7 days)
(1) Medicine Name: Jatamayadi Kasmaya, Reference: Sahasrayoga, Taila Yoga Prakarana, Route: Topical, Dosage Form: Kwatha/Kashaya, Dose: 2000(ml), Frequency: od, Duration: 7 Days
2Comparator ArmProcedure-shirodhar (Procedure Reference: As per the Classical text and Shirodhara Protocol, Procedure details: Shirodhara with Jala (Plain Water), 52 minutes daily for 7 days)
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Patients of Pre hypertension without taking any anti hypertensive drug.
Either sex, irrespective of religion and caste.
Prehypertension (SBP 120 to 139 mm Hg and DBP 80 to 89 mm Hg).
 
 
ExclusionCriteria 
Details  Patients below 20 yr and above 50 yr.
Patients with Stage 1 HTN and Stage 2 HTN.
Patients receiving antihypertensive drug.
Patients having any other systemic disease or complications. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Jatamayadi Kashayadhara in Pre-Hypertension when measured in Sphygnomanometer, WHO’s QOL Scale and on the basis of signs and symptoms of Pre-Hypertension.
To evaluate the efficacy of Jaladhara in Pre-Hypertension when measured in WHO’s QOL Scale and on the basis of signs and symptoms of Pre-Hypertension.
To compare the efficacy of Jatamayadi Kashayadhara and Jaladhara in Pre-Hypertension
 
Total duration of study is 14 days
with observation
Initially on the first day before treatment.
On the 7th day after treatment.
On the 14th day for late assessment.
 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in subjective symptoms of Pre-Hypertension (e.g., headache, dizziness, irritability, fatigue, insomnia, belching, burning sensation)
Improvement in WHO Quality of Life (QOL) score 
Day 1 (before treatment), Day 7 (after intervention), and Day 14 (follow-up) 
 
Target Sample Size   Total Sample Size="136"
Sample Size from India="136" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="14" 
Recruitment Status of Trial (Global)   Closed to Recruitment of Participants 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Data are available indefinitely at (Link to be included drreshmibabu@gmail.com).

  6. For how long will this data be available start date provided 10-08-2025 and end date provided 08-07-2030?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary  
This is a randomized, parallel-group, active-controlled, interventional clinical trial designed to compare the efficacy of Kashayadhara (using Jatamayadi Kashaya) and Jaladhara (using plain water) in patients with pre-hypertension. A total of 140 participants diagnosed with pre-hypertension will be randomly allocated into two groups:
Group A: Kashayadhara
Group B: Jaladhara

Each intervention will be administered as Shirodhara for 52 minutes daily over 7 days, followed by a late assessment on Day 14.
The primary outcome is the change in blood pressure measured by sphygmomanometer.
Secondary outcomes include improvements in subjective symptoms and WHO Quality of Life Scale (QOL).
The study will be conducted at the Department of Panchakarma, G S Ayurveda Medical college and Hospital, Pilakhuwa, Hapur Dist
This trial aims to explore and validate the efficacy of  Ayurvedic Panchakarma therapies in managing early-stage high blood pressure.
 
Close